Astaxanthin in dogs: the evidence
What the aging-research databases and the canine literature hold for Astaxanthin (names searched: Astaxanthin). Compiled from DrugAge, the canine aging corpus and FDA CVM FOI summaries; nothing here is inferred.
Lifespan experiments in other species (DrugAge)
6 experiments recorded, by species: Caenorhabditis elegans 4, Mus musculus 2.
NIA Interventions Testing Program rows
| Species | Strain | Dose | Age at start | Duration | Sex | Mean lifespan Δ% | Mean sig. | Max lifespan Δ% | Max sig. | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Mus musculus | UM-HET3 | 4000 ppm food | 12 months | until death | Female | 3 | NS | -1 | NS | PMID 38041783 |
| Mus musculus | UM-HET3 | 4000 ppm food | 12 months | until death | Male | 12 | S | 6 | NS | PMID 38041783 |
Other DrugAge rows (sample)
| Species | Strain | Dose | Age at start | Duration | Sex | Mean lifespan Δ% | Mean sig. | Max lifespan Δ% | Max sig. | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | N2 | 1 mM | Unknown | 28.6 | S | 21.7 | NA | PMID 22013497 | ||
| Caenorhabditis elegans | N2 | 6 µg | Unknown | 20.8 | S | 14.6 | NA | PMID 22484623 | ||
| Caenorhabditis elegans | N2 | 120 µM | Unknown | 13.36 | S | NA | PMID 33115330 | |||
| Caenorhabditis elegans | N2 | 60 µM | Unknown | 9.71 | S | NA | PMID 33115330 |
Lifespan experiments in dogs (DrugAge)
DrugAge records no dog lifespan experiment for this compound.
Dog-equivalent doses (allometric starting points, not recommendations)
Method: FDA 2005 Km body-surface-area conversion; starting-point heuristic only.
No mg/kg dose in DrugAge to translate (doses reported as ppm of diet or a concentration).
Canine aging literature (Europe PMC corpus)
6 corpus records mention this compound.
Top hits in the core tier
- METHODS AND COMPOSITIONS UTILIZING ASTAXANTHIN. (, 2005).
- METHODS AND COMPOSITIONS UTILIZING ASTAXANTHIN (, 2005).
- METHODS AND COMPOSITIONS UTILIZING ASTAXANTHIN (, 2004).
- Methods and compositions utilizing astaxanthin (, 2004).
- Astaxanthin modulates age-associated mitochondrial dysfunction in healthy dogs. (Journal of animal science, 2013). PMID 23100599
- A protein- and fiber-rich diet with astaxanthin alleviates high-fat diet-induced obesity in beagles. (Frontiers in nutrition, 2022). PMID 36352906
Trials and cohorts in the canine aging trial registry
- Dietary astaxanthin and age-associated mitochondrial dysfunction in young and geriatric Beagles (completed): Mitochondrial function improved in both young and geriatric dogs by increasing (P<0.05) ATP production, mitochondria mass, and cytochrome c oxidoreductase activity, especially in geriatric dogs compared with young dogs; astaxanthin also increased the reduced to oxidized glutathione ratio in young dogs and decreased nitric oxide in both age groups. Dietary astaxanthin improved mitochondrial function in blood leukocytes, most likely by alleviating oxidative damage to cellular DNA and protein.
FDA CVM FOI summaries for dog products
No FDA FOI summary for a dog product contains this ingredient (it is not a marketed veterinary product).
Evidence gaps reported by the dossier tool
- DrugAge has no dog lifespan experiment for this compound.
- Corpus mentions exist but no randomized/placebo-controlled dog trial surfaced for it.
- No mg/kg animal dose in DrugAge to translate (doses reported as ppm or % of diet).
- No FDA FOI summary for a dog product containing this ingredient.
Reproduce: intervention_dossier(compound="Astaxanthin") in dog-geroscience-mcp.